Loading...
A case of long-term dasatinib-induced proteinuria and glomerular injury
A 52-year-old woman was diagnosed with chronic myeloid leukemia. Treatment with dasatinib, a second-generation Bcr–Abl tyrosine kinase inhibitor, was initiated, and complete cytogenetic remission was achieved. Two years later, proteinuria occurred, and the urinary protein level increased gradually i...
Na minha lista:
| Udgivet i: | CEN Case Rep |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Singapore
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7502092/ https://ncbi.nlm.nih.gov/pubmed/32388829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13730-020-00484-8 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|